Cardlytics Inc. Stock News

Shares of Cardlytics, Inc. (NASDAQ:CDLX) have earned an average recommendation of Hold from the nine ratings firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company. The average 12 month []

During the last session, Cardlytics Inc. (NASDAQ:CDLX)s traded shares were 0.36 million, with the beta value of the company hitting 2.37. At the end of the trading day, the stocks price was $72.54, reflecting an intraday gain of 4.83% or $3.34. The 52-week high for the CDLX share is $161.47, that puts it down -122.59 Is Cardlytics Inc. (NASDAQ: CDLX) Still A Buy After sinking -12.66% Last Week? Read More »

Price T Rowe Associates Inc. MD cut its position in shares of Cardlytics, Inc. (NASDAQ:CDLX) by 2.8% in the second quarter, Holdings Channel.com reports. The firm owned 14,823 shares of the companys stock after selling 423 shares during the quarter. Price T Rowe Associates Inc. MDs holdings in Cardlytics were worth $1,881,000 at the end []

Cardlytics, Inc. (NASDAQ:CDLX) Director Scott D. Grimes sold 6,000 shares of Cardlytics stock in a transaction on Thursday, November 18th. The shares were sold at an average price of $78.46, for a total value of $470,760.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through []

Marshall Wace North America L.P. reduced its stake in Cardlytics, Inc. (NASDAQ:CDLX) by 23.0% during the 2nd quarter, HoldingsChannel reports. The fund owned 24,568 shares of the companys stock after selling 7,355 shares during the quarter. Marshall Wace North America L.P.s holdings in Cardlytics were worth $3,118,000 as of its most recent SEC filing. Other []

Related Stocks: GDYN , TRMR , HYRE , AXON , DOCS , DOCN , DOMO , ZIP , TBLA , TBLA , SMLR , EMKR , FIVN , SIBN , AOUT , CDLX , LPSN , VICR ,

Related Stocks: PRPL , FVRR , FICO , DAVA , COUP , ELY , FTCH , VSCO , JAMF , JAMF , FRPT , VAC , FB , CDLX , SAM , CSGP , CHWY , S ,

Craig-Hallum analyst Jason Kreyer lowered the price target on Cardlytics Inc (NASDAQ: CDLX) to $100 from $120, implying a 25.4% upside, and reiterated a Buy.  While broader macro concerns over s

Cardlytics, Inc. (CDLX) CEO Lynne Laube on Q3 2021 Results - Earnings Call Transcript

Cardlytics (CDLX) delivered earnings and revenue surprises of 34.00% and 4.14%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

ATLANTA, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), a digital advertising platform, today announced that its third quarter ended September 30, 2021 financial results will be r

ATLANTA, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Cardlytics (NASDAQ: CDLX), a digital advertising platform, today announced the appointment of Chris Suh, corporate vice president and CFO, Cloud+ AI Group a

Bulls do damage control after poor earnings guide.

CDLX, UUUU, IVC, PSTX, and CYTK have been added to the Zacks Rank #5 (Strong Sell) List on August 27, 2021

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Cardlytics, I